table of content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Brand Drugs Market Size Analysis from 2022 to 2027
1.5.1 Global Brand Drugs Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Brand Drugs Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Brand Drugs Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Brand Drugs Industry Impact
Chapter 2 Global Brand Drugs Competition by Types, Applications, and Top Regions and Countries
2.1 Global Brand Drugs (Volume and Value) by Type
2.1.1 Global Brand Drugs Consumption and Market Share by Type (2016-2021)
2.1.2 Global Brand Drugs Revenue and Market Share by Type (2016-2021)
2.2 Global Brand Drugs (Volume and Value) by Application
2.2.1 Global Brand Drugs Consumption and Market Share by Application (2016-2021)
2.2.2 Global Brand Drugs Revenue and Market Share by Application (2016-2021)
2.3 Global Brand Drugs (Volume and Value) by Regions
2.3.1 Global Brand Drugs Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Brand Drugs Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Brand Drugs Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Brand Drugs Consumption by Regions (2016-2021)
4.2 North America Brand Drugs Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Brand Drugs Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Brand Drugs Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Brand Drugs Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Brand Drugs Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Brand Drugs Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Brand Drugs Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Brand Drugs Sales, Consumption, Export, Import (2016-2021)
4.10 South America Brand Drugs Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Brand Drugs Market Analysis
5.1 North America Brand Drugs Consumption and Value Analysis
5.1.1 North America Brand Drugs Market Under COVID-19
5.2 North America Brand Drugs Consumption Volume by Types
5.3 North America Brand Drugs Consumption Structure by Application
5.4 North America Brand Drugs Consumption by Top Countries
5.4.1 United States Brand Drugs Consumption Volume from 2016 to 2021
5.4.2 Canada Brand Drugs Consumption Volume from 2016 to 2021
5.4.3 Mexico Brand Drugs Consumption Volume from 2016 to 2021
Chapter 6 East Asia Brand Drugs Market Analysis
6.1 East Asia Brand Drugs Consumption and Value Analysis
6.1.1 East Asia Brand Drugs Market Under COVID-19
6.2 East Asia Brand Drugs Consumption Volume by Types
6.3 East Asia Brand Drugs Consumption Structure by Application
6.4 East Asia Brand Drugs Consumption by Top Countries
6.4.1 China Brand Drugs Consumption Volume from 2016 to 2021
6.4.2 Japan Brand Drugs Consumption Volume from 2016 to 2021
6.4.3 South Korea Brand Drugs Consumption Volume from 2016 to 2021
Chapter 7 Europe Brand Drugs Market Analysis
7.1 Europe Brand Drugs Consumption and Value Analysis
7.1.1 Europe Brand Drugs Market Under COVID-19
7.2 Europe Brand Drugs Consumption Volume by Types
7.3 Europe Brand Drugs Consumption Structure by Application
7.4 Europe Brand Drugs Consumption by Top Countries
7.4.1 Germany Brand Drugs Consumption Volume from 2016 to 2021
7.4.2 UK Brand Drugs Consumption Volume from 2016 to 2021
7.4.3 France Brand Drugs Consumption Volume from 2016 to 2021
7.4.4 Italy Brand Drugs Consumption Volume from 2016 to 2021
7.4.5 Russia Brand Drugs Consumption Volume from 2016 to 2021
7.4.6 Spain Brand Drugs Consumption Volume from 2016 to 2021
7.4.7 Netherlands Brand Drugs Consumption Volume from 2016 to 2021
7.4.8 Switzerland Brand Drugs Consumption Volume from 2016 to 2021
7.4.9 Poland Brand Drugs Consumption Volume from 2016 to 2021
Chapter 8 South Asia Brand Drugs Market Analysis
8.1 South Asia Brand Drugs Consumption and Value Analysis
8.1.1 South Asia Brand Drugs Market Under COVID-19
8.2 South Asia Brand Drugs Consumption Volume by Types
8.3 South Asia Brand Drugs Consumption Structure by Application
8.4 South Asia Brand Drugs Consumption by Top Countries
8.4.1 India Brand Drugs Consumption Volume from 2016 to 2021
8.4.2 Pakistan Brand Drugs Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Brand Drugs Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Brand Drugs Market Analysis
9.1 Southeast Asia Brand Drugs Consumption and Value Analysis
9.1.1 Southeast Asia Brand Drugs Market Under COVID-19
9.2 Southeast Asia Brand Drugs Consumption Volume by Types
9.3 Southeast Asia Brand Drugs Consumption Structure by Application
9.4 Southeast Asia Brand Drugs Consumption by Top Countries
9.4.1 Indonesia Brand Drugs Consumption Volume from 2016 to 2021
9.4.2 Thailand Brand Drugs Consumption Volume from 2016 to 2021
9.4.3 Singapore Brand Drugs Consumption Volume from 2016 to 2021
9.4.4 Malaysia Brand Drugs Consumption Volume from 2016 to 2021
9.4.5 Philippines Brand Drugs Consumption Volume from 2016 to 2021
9.4.6 Vietnam Brand Drugs Consumption Volume from 2016 to 2021
9.4.7 Myanmar Brand Drugs Consumption Volume from 2016 to 2021
Chapter 10 Middle East Brand Drugs Market Analysis
10.1 Middle East Brand Drugs Consumption and Value Analysis
10.1.1 Middle East Brand Drugs Market Under COVID-19
10.2 Middle East Brand Drugs Consumption Volume by Types
10.3 Middle East Brand Drugs Consumption Structure by Application
10.4 Middle East Brand Drugs Consumption by Top Countries
10.4.1 Turkey Brand Drugs Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Brand Drugs Consumption Volume from 2016 to 2021
10.4.3 Iran Brand Drugs Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Brand Drugs Consumption Volume from 2016 to 2021
10.4.5 Israel Brand Drugs Consumption Volume from 2016 to 2021
10.4.6 Iraq Brand Drugs Consumption Volume from 2016 to 2021
10.4.7 Qatar Brand Drugs Consumption Volume from 2016 to 2021
10.4.8 Kuwait Brand Drugs Consumption Volume from 2016 to 2021
10.4.9 Oman Brand Drugs Consumption Volume from 2016 to 2021
Chapter 11 Africa Brand Drugs Market Analysis
11.1 Africa Brand Drugs Consumption and Value Analysis
11.1.1 Africa Brand Drugs Market Under COVID-19
11.2 Africa Brand Drugs Consumption Volume by Types
11.3 Africa Brand Drugs Consumption Structure by Application
11.4 Africa Brand Drugs Consumption by Top Countries
11.4.1 Nigeria Brand Drugs Consumption Volume from 2016 to 2021
11.4.2 South Africa Brand Drugs Consumption Volume from 2016 to 2021
11.4.3 Egypt Brand Drugs Consumption Volume from 2016 to 2021
11.4.4 Algeria Brand Drugs Consumption Volume from 2016 to 2021
11.4.5 Morocco Brand Drugs Consumption Volume from 2016 to 2021
Chapter 12 Oceania Brand Drugs Market Analysis
12.1 Oceania Brand Drugs Consumption and Value Analysis
12.2 Oceania Brand Drugs Consumption Volume by Types
12.3 Oceania Brand Drugs Consumption Structure by Application
12.4 Oceania Brand Drugs Consumption by Top Countries
12.4.1 Australia Brand Drugs Consumption Volume from 2016 to 2021
12.4.2 New Zealand Brand Drugs Consumption Volume from 2016 to 2021
Chapter 13 South America Brand Drugs Market Analysis
13.1 South America Brand Drugs Consumption and Value Analysis
13.1.1 South America Brand Drugs Market Under COVID-19
13.2 South America Brand Drugs Consumption Volume by Types
13.3 South America Brand Drugs Consumption Structure by Application
13.4 South America Brand Drugs Consumption Volume by Major Countries
13.4.1 Brazil Brand Drugs Consumption Volume from 2016 to 2021
13.4.2 Argentina Brand Drugs Consumption Volume from 2016 to 2021
13.4.3 Columbia Brand Drugs Consumption Volume from 2016 to 2021
13.4.4 Chile Brand Drugs Consumption Volume from 2016 to 2021
13.4.5 Venezuela Brand Drugs Consumption Volume from 2016 to 2021
13.4.6 Peru Brand Drugs Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Brand Drugs Consumption Volume from 2016 to 2021
13.4.8 Ecuador Brand Drugs Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Brand Drugs Business
14.1 Pfizer
14.1.1 Pfizer Company Profile
14.1.2 Pfizer Brand Drugs Product Specification
14.1.3 Pfizer Brand Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Roche
14.2.1 Roche Company Profile
14.2.2 Roche Brand Drugs Product Specification
14.2.3 Roche Brand Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 Sanofi
14.3.1 Sanofi Company Profile
14.3.2 Sanofi Brand Drugs Product Specification
14.3.3 Sanofi Brand Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Johnson & Johnson
14.4.1 Johnson & Johnson Company Profile
14.4.2 Johnson & Johnson Brand Drugs Product Specification
14.4.3 Johnson & Johnson Brand Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Merck & Co. (MSD)
14.5.1 Merck & Co. (MSD) Company Profile
14.5.2 Merck & Co. (MSD) Brand Drugs Product Specification
14.5.3 Merck & Co. (MSD) Brand Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 Novartis
14.6.1 Novartis Company Profile
14.6.2 Novartis Brand Drugs Product Specification
14.6.3 Novartis Brand Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 AbbVie
14.7.1 AbbVie Company Profile
14.7.2 AbbVie Brand Drugs Product Specification
14.7.3 AbbVie Brand Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Gilead Sciences
14.8.1 Gilead Sciences Company Profile
14.8.2 Gilead Sciences Brand Drugs Product Specification
14.8.3 Gilead Sciences Brand Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 GlaxoSmithKline (GSK)
14.9.1 GlaxoSmithKline (GSK) Company Profile
14.9.2 GlaxoSmithKline (GSK) Brand Drugs Product Specification
14.9.3 GlaxoSmithKline (GSK) Brand Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 Amgen
14.10.1 Amgen Company Profile
14.10.2 Amgen Brand Drugs Product Specification
14.10.3 Amgen Brand Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.11 AstraZeneca
14.11.1 AstraZeneca Company Profile
14.11.2 AstraZeneca Brand Drugs Product Specification
14.11.3 AstraZeneca Brand Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.12 Bristol-Myers Squibb
14.12.1 Bristol-Myers Squibb Company Profile
14.12.2 Bristol-Myers Squibb Brand Drugs Product Specification
14.12.3 Bristol-Myers Squibb Brand Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.13 Eli Lilly
14.13.1 Eli Lilly Company Profile
14.13.2 Eli Lilly Brand Drugs Product Specification
14.13.3 Eli Lilly Brand Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.14 Teva
14.14.1 Teva Company Profile
14.14.2 Teva Brand Drugs Product Specification
14.14.3 Teva Brand Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.15 Bayer
14.15.1 Bayer Company Profile
14.15.2 Bayer Brand Drugs Product Specification
14.15.3 Bayer Brand Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.16 Novo Nordisk
14.16.1 Novo Nordisk Company Profile
14.16.2 Novo Nordisk Brand Drugs Product Specification
14.16.3 Novo Nordisk Brand Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.17 Allergan
14.17.1 Allergan Company Profile
14.17.2 Allergan Brand Drugs Product Specification
14.17.3 Allergan Brand Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.18 Shire
14.18.1 Shire Company Profile
14.18.2 Shire Brand Drugs Product Specification
14.18.3 Shire Brand Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.19 Boehringer Ingelheim
14.19.1 Boehringer Ingelheim Company Profile
14.19.2 Boehringer Ingelheim Brand Drugs Product Specification
14.19.3 Boehringer Ingelheim Brand Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.20 Takeda
14.20.1 Takeda Company Profile
14.20.2 Takeda Brand Drugs Product Specification
14.20.3 Takeda Brand Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Brand Drugs Market Forecast (2022-2027)
15.1 Global Brand Drugs Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Brand Drugs Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Brand Drugs Value and Growth Rate Forecast (2022-2027)
15.2 Global Brand Drugs Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Brand Drugs Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Brand Drugs Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Brand Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Brand Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Brand Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Brand Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Brand Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Brand Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Brand Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Brand Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Brand Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Brand Drugs Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Brand Drugs Consumption Forecast by Type (2022-2027)
15.3.2 Global Brand Drugs Revenue Forecast by Type (2022-2027)
15.3.3 Global Brand Drugs Price Forecast by Type (2022-2027)
15.4 Global Brand Drugs Consumption Volume Forecast by Application (2022-2027)
15.5 Brand Drugs Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
